For ccf nDNA, our previous studies indicated that in comparison with other potential circulating biomarkers involved in malignancy, such as nucleosomes, vascular endothelial growth factor (VEGF) and its soluble receptor (sVEGFR1), the ccf DNA showed more sensitivity and specificity in discriminating between breast cancer and normal controls [19,20]. Here, VEGFA is linked to breast cancer.